Analysis of HCM in an understudied population reveals a new mechanism of pathogenicity
Yasmine AguibiD, Mona AlloubaiD, Roddy WalshiD, Ayman Maher IbrahimiD, Sarah HalawaiD, Alaa Afify, Mohamed HosnyiD, Pantazis I. TheotokisiD, Aya A. GalaliD, Sara ElshorbagyiD, Mohamed RoshdyiD, Heba Sh. KassemiD, Amany EllithyiD, Rachel J. BuchaniD, Nicola WhiffiniD, Shehab AnweriD, Stuart A. CookiD, Ahmed MoustafaiD, Ahmed Mohamed ElGuindyiD, James S. WareiD, Paul J.R. BartoniD, Magdi Habib YacoubiD
Abstract
Hypertrophic Cardiomyopathy (HCM) is an inherited disease characterized by genetic and phenotypic heterogeneity. MYH7 represents one of the main sarcomere-encoding genes associated with HCM. Missense variants in this gene cause HCM through gain-of-function actions, whereby variants produce an abnormal activated protein which incorporates into the sarcomere as a poison peptide. Here we report a frameshift variant in MYH7, c.5769delG, that is associated with HCM in an Egyptian cohort (3.3%) compared with ethnically-matched controls. This variant is absent from previously published large-scale Caucasian HCM cohorts. We further demonstrate strong evidence of co-segregation of c.5769delG with HCM in a large family (LOD score: 3.01). The predicted sequence of the variant MYH7 transcript shows that the frameshift results in a premature termination codon (PTC) downstream of the last exon-exon junction of the gene that is expected to escape nonsense-mediated decay (NMD). RNA sequencing of myocardial tissue obtained from a patient with the variant during surgical myectomy confirmed the expression of the variant MYH7 transcript. Our analysis reveals a new mechanism of pathogenicity in the understudied Egyptian population whereby distal PTC in MYH7 may lead to the expression of an abnormal protein.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 8
- FWCI
- 0.67
- Field percentile
- top 29%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel frameshift variant in MYL2 reveals molecular differences between dominant and recessive forms of hypertrophic cardiomyopathy
Sathiyanarayanan Manivannan, Sihem Darouich, … Vidu Garg·PLoS GeneticsPeer-reviewed·May 26, 2020
- Comprehensive Genetic Study of Russian Hypertrophic Cardiomyopathy Identifies MYBPC3 c.3697C>T as the Predominant Variant in Pediatric and Adult Cohorts
Leila A. Gandaeva, Чумакова Ольга Сергеевна, … Kirill Victorovich Savostyanov·medRxiv·Nov 5, 2025
- Beta-Adrenergic Stimulation and MYH7 G256E Mutant Gene Dosage Drive Hypertrophic Cardiomyopathy Phenotype Penetrance
Paul V. Heinrich, Raina M. Jung, … Sean M. Wu·bioRxiv·Jun 6, 2026
- Outcomes and phenotypic expression of rare variants in hypertrophic cardiomyopathy genes amongst UK Biobank participants
Antonio de Marvao, Kathryn A. McGurk, … Declan P. O’Regan·Journal of the American College of CardiologyPeer-reviewed·Sep 1, 2021
- Hypertrophic cardiomyopathy disease results from disparate impairments of cardiac myosin function and auto-inhibition
J. Robert-Paganin, D. Auguin, A. Houdusse·bioRxiv·May 17, 2018
- Genotype-Phenotype Correlations Identify Phenotypic Differences in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy in the NHLBI HCM Registry
Jonathan Chan, Christopher Grace, … Anuj Goel·medRxiv·Jul 30, 2026